학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 67건 | 목록 1~20
Academic Journal
Blood
Digital.CSIC. Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Dreyling, M, Fowler, N H, Dickinson, M, Martinez-Lopez, J, Kolstad, A, Butler, J, Patten, P EM, Thieblemont, C & Schuster, S J 2024, ' Durable Response After Tisagenlecleucel in Adults With Relapsed/Refractory Follicular Lymphoma: ELARA Trial Update ', Blood, vol. 143, no. 17, pp. 1713-1725 . https://doi.org/10.1182/blood.2023021567
BLOOD
Academic Journal
Cancila V; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Bertolazzi G; Department of Medicine and Surgery, Kore University of Enna, Enna, Italy.; Chan AS; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Medico G; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, New York, USA.; Bastianello G; Genome Integrity Lab, IFOM ETS-The Italian Association for Cancer Research (AIRC) Institute of Molecular Oncology, Milan, Italy.; Morello G; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Paysan D; Laboratory for Nanoscale Biology, Paul Scherrer Institute, Villigen, Switzerland.; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.; Lai C; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Hong L; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Shenoy G; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Jaynes PW; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Schiavoni G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.; Mattei F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.; Piconese S; Department of Internal Clinical Sciences, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, Unità di Neuroimmunologia, Rome, Italy.; Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.; Revuelta MV; Division of Hematology and Oncology, Medicine Department, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, New York, USA.; Noto F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.; Businaro L; Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy.; De Ninno A; Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy.; Cammarata I; Department of Translational and Precision Medicine, Sapienza University of Rome, Neuroimmunology Unit, IRCCS Fondazione Santa Lucia, Rome, Italy.; Pagni F; Department of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Milan, Italy.; Venkatachalapathy S; Laboratory for Nanoscale Biology, Paul Scherrer Institute, Villigen, Switzerland.; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.; Sangaletti S; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Di Napoli A; Pathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, Italy.; Cicio G; Advanced Pathology Laboratory, IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Vacca D; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Lonardi S; Pathology Unit, ASST Spedali Civili di Brescia, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; Lorenzi L; Pathology Unit, ASST Spedali Civili di Brescia, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; Ferreri AJ; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.; Belmonte B; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Liu M; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China.; Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; Lakshmanan M; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Singapore.; Ong MS; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Singapore.; Zhang B; Singapore Immunology Network, ASTAR, Singapore.; See T; Singapore Immunology Network, ASTAR, Singapore.; Lam KP; Singapore Immunology Network, ASTAR, Singapore.; Department of Microbiology and Immunology, Immunology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore.; Varano G; Genetics of B Cells and Lymphoma Unit, IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Colombo MP; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Bicciato S; Department of Molecular Medicine, University of Padova, Padova, Italy.; Inghirami G; Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, New York, USA.; Cerchietti L; Division of Hematology and Oncology, Medicine Department, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, New York, USA.; Ponzoni M; Vita-Salute San Raffaele University, Milan, Italy.; Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Zappasodi R; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.; Metzger E; Bruker Spatial Biology, Seattle, Washington, USA.; Beechem J; Bruker Spatial Biology, Seattle, Washington, USA.; Facchetti F; Pathology Unit, ASST Spedali Civili di Brescia, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; Foiani M; Genome Integrity Lab, IFOM ETS-The Italian Association for Cancer Research (AIRC) Institute of Molecular Oncology, Milan, Italy.; Casola S; Genetics of B Cells and Lymphoma Unit, IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.; Jeyasekharan AD; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Health System, Singapore.; NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, and.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Tripodo C; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Advanced Pathology Laboratory, IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Ferreri, Andres JM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어